CUBIST PHARMACEUTICALS INC 01/22/2015Non-Confidential (CBST1)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Robert J. Perez
Employees:
65 HAYDEN AVENUE, LEXINGTON, MA 02421
781-860-8660

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of pharmaceutical products for medical needs in the acute care environment in the United States.

Data derived from most recent annual or quarterly report
Market Cap 7.79 Billion Shares Outstanding76.42 Million Avg 30-day Volume 2.671 Million
P/E Ratio87.6553 Dividend Yield0.0 EPS0.85
Price to Revenue4.8989 Debt to Equity0.5892 EBITDA261.925 Million
Price to Book Value3.7054 Operating Margin10.543 Enterprise Value5.925 Billion
Current Ratio3.537 EPS Growth1.353 Quick Ratio2.918
1 Yr BETA 0.9887 52-week High/Low 0.0 / Profit Margin5.5889
Operating Cash Flow Growth104.7176 Altman Z-Score2.8838 Free Cash Flow to Firm -452.444 Million
View SEC Filings from CBST1 instead.

View recent insider trading info

Funds Holding CBST1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CBST1

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARTIN KENNETH J

  • Director
No longer subject to file 2015-01-21 0

HENNEY JANE E MD

  • Director
No longer subject to file 2015-01-21 0

BATE KENNETH

  • Director
No longer subject to file 2015-01-21 0

BONNEY MICHAEL W CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2015-01-21 0

MOULDER LEON O JR

  • Director
No longer subject to file 2015-01-21 0

CORRIGAN MARK

  • Director
No longer subject to file 2015-01-21 0

PEREZ ROBERT J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2015-01-21 0

SOETERS MARTINUS HERMANUS

  • Director
No longer subject to file 2015-01-21 0

HUTSON NANCY J

  • Director
No longer subject to file 2015-01-21 0

GILMAN STEVEN C EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2015-01-21 0

DESROSIER THOMAS EVP, CHIEF LEGAL

  • Officer
  • AND ADMINISTRATIVE OFFICER
No longer subject to file 2015-01-21 0

LAWTON ALISON FRANCES

  • Director
No longer subject to file 2015-01-21 0

VINK PATRICK V.J.J. EVP AND COO

  • Officer
No longer subject to file 2015-01-21 0

TOMSICEK MICHAEL JOHN SVP & CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2015-01-21 0

STEA GREGORY SVP, COMMERCIAL OPERATIONS

  • Officer
18,689 2014-09-30 0

ROSENBERG MARTIN

  • Director
6,005 2013-09-09 0

SINGLETON J MATTHEW

  • Director
0 2013-06-12 0

WOOD MICHAEL B

  • Director
0 2013-06-12 0

LARANJEIRA CHARLES ANTHONY SVP, TECHNICAL OPERATIONS

  • Officer
1,833 2013-05-20 0

MCGIRR DAVID W J SVP & CHIEF FINANCIAL OFFICER

  • Officer
23,980 2013-02-15 0

JOSEPH TAMARA L SVP, GC & SECRETARY

  • Officer
19,699 2012-06-29 0

VETTICADEN SANTOSH SVP & CHIEF MEDICAL OFFICER

  • Officer
8,773 2011-12-30 0

GREGOIRE SYLVIE

  • Director
5,085 2010-06-10 0

FELLOWS LINDON M SENIOR VICE PRESIDENT

  • Officer
5,992 2010-03-31 0

MAUPAY WALTER R JR

  • Director
27,157 2009-08-26 0

MARTIN DAVID W JR

  • Director
32,261 2008-06-11 0

GUIFFRE CHRISTOPHERD T SENIOR VICE PRESIDENT

  • Officer
5,359 2008-03-31 0

PULLMAN WILLIAM E SVP, CHIEF MEDICAL OFFICER

  • Officer
0 2007-10-31 0

FETZER OLIVER SENIOR VICE PRESIDENT

  • Officer
0 2007-09-14 0

ARCHER GORDON LEE

  • Director
0 2007-08-28 0

TALLY FRANCIS P SENIOR VICE PRESIDENT

  • Officer
10,000 2006-06-16 0

EISENSTEIN BARRY I SENIOR VICE PRESIDENT

  • Officer
0 2006-03-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments